Article (Scientific journals)
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip
Luyten, F. P.; Geusens, P.; Malaise, Michel et al.
2007In Annals of the Rheumatic Diseases, 66 (1), p. 99-106
Peer Reviewed verified by ORBi
 

Files


Full Text
Malaise_2007_AnnRheumDis_99-106.pdf
Publisher postprint (274.37 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Pyrazoles; Sulfonamides; Ibuprofen; celecoxib
Abstract :
[en] Objective: To compare the effects of continuous and intermittent celecoxib treatment in patients with knee or hip osteoarthritis in flare. Methods: In this 24-week, prospective, randomised, double-blind, placebo-controlled study, patients were randomly assigned to receive continuous (n = 62) or intermittent (n = 61) treatment with celecoxib 200 mg once daily. The primary efficacy end point was the area under the curve (AUC) of the change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total scores between baseline and week 24 divided by the time interval. Secondary end points included the percentage of days with intake of the flare drug, the AUC of the change in the WOMAC total scores, the mean change from baseline in the WOMAC scores, and the patient's and physician's global assessment of osteoarthritis. Results: There were no significant differences between patients randomised to continuous or intermittent treatment in the primary end point or most of the secondary end points, although a consistent trend supporting continuous treatment was observed. The percentage of days with intake of the flare drug was significantly lower (p = 0.031) in the group receiving continuous versus intermittent celecoxib. Both treatment regimens were well tolerated. Conclusion: The results of this pilot study indicate a potential clinical difference between continuous and intermittent treatment with celecoxib, and may be useful in designing future trials. A larger trial on both efficacy and safety outcomes is required for conclusive evidence in favour of either continuous or intermittent treatment.
Disciplines :
Rheumatology
Author, co-author :
Luyten, F. P.
Geusens, P.
Malaise, Michel ;  Université de Liège - ULiège > Département des sciences cliniques > Rhumatologie
De Clerck, L.
Westhovens, R.
Raeman, F.
Vander Mijnsbrugge, D.
Mathy, Luc ;  Centre Hospitalier Universitaire de Liège - CHU > Rhumatologie
Hauzeur, Jean-Philippe ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
De Keyser, F.
Van den Bosch, F.
Language :
English
Title :
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip
Publication date :
January 2007
Journal title :
Annals of the Rheumatic Diseases
ISSN :
0003-4967
eISSN :
1468-2060
Publisher :
BMJ Group, London, United Kingdom
Volume :
66
Issue :
1
Pages :
99-106
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 19 September 2010

Statistics


Number of views
65 (5 by ULiège)
Number of downloads
182 (4 by ULiège)

Scopus citations®
 
24
Scopus citations®
without self-citations
24
OpenCitations
 
22

Bibliography


Similar publications



Contact ORBi